» Articles » PMID: 30529020

The Human Microbiome and Child Growth - First 1000 Days and Beyond

Overview
Date 2018 Dec 12
PMID 30529020
Citations 303
Authors
Affiliations
Soon will be listed here.
Abstract

The assembly of microbial communities within the gastrointestinal tract during early life plays a critical role in immune, endocrine, metabolic, and other host developmental pathways. Environmental insults during this period, such as food insecurity and infections, can disrupt this optimal microbial succession, which may contribute to lifelong and intergenerational deficits in growth and development. Here, we review the human microbiome in the first 1000 days - referring to the period from conception to 2 years of age - and using a developmental model, we examine the role of early microbial succession in growth and development. We propose that an 'undernourished' microbiome is intergenerational, thereby perpetuating growth impairments into successive generations. We also identify and discuss the intertwining host-microbe-environment interactions occurring prenatally and during early infancy, which may impair the trajectories of healthy growth and development, and explore their potential as novel microbial targets for intervention.

Citing Articles

Infant development at 14 months in the context of maternal objective and subjective birth experience and infant hair glucocorticoids.

Jaramillo I, Bergunde L, Muller-Stark C, Karl M, Weise V, Kirschbaum C BMC Pediatr. 2025; 25(1):191.

PMID: 40087629 DOI: 10.1186/s12887-025-05528-5.


Early-life gut microbiome is associated with behavioral disorders in the Rio birth cohort.

Naspolini N, Natividade A, Asmus C, Moreira J, Dominguez-Bello M, Meyer A Sci Rep. 2025; 15(1):8674.

PMID: 40082490 PMC: 11906608. DOI: 10.1038/s41598-024-81774-4.


Relevance of Milk Composition to Human Longitudinal Growth from Infancy Through Puberty: Facts and Controversies.

Borer K Nutrients. 2025; 17(5).

PMID: 40077697 PMC: 11901938. DOI: 10.3390/nu17050827.


Disruption and adaptation: infant gut microbiota's dynamic response to SARS-CoV-2 infection.

Zhu L, Zhao L, Zhu Y, Xu X, Lin J, Duan Y Microbiome. 2025; 13(1):72.

PMID: 40069800 PMC: 11895207. DOI: 10.1186/s40168-025-02029-6.


NapBiome trial: Targeting gut microbiota to improve sleep rhythm and developmental and behavioural outcomes in early childhood in a birth cohort in Switzerland - a study protocol.

Zimmermann P, Kurth S, Giannoukos S, Stocker M, Bokulich N BMJ Open. 2025; 15(3):e092938.

PMID: 40032396 PMC: 11877202. DOI: 10.1136/bmjopen-2024-092938.